v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value

The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three and six months ended June 30, 2026 and 2025, there were no transfers between Levels 2 and 3.

    June 30, 2026
    Total   Level 1   Level 2   Level 3
Assets:                
Recurring fair value measurements:                                
Cash equivalents   $ 120,282     $ 120,282     $     $  
Financial instruments owned, at fair value:                                
ETFs     14,594       14,594              
Pass-through GSEs     4,011             4,011        
Other assets—seed capital (WisdomTree Digital Funds):                                
U.S. treasuries     4,708             4,708        
Equities     11,978       11,978              
Fixed income     2,361       1,016       1,345        
Total   $ 157,934     $ 147,870     $ 10,064     $  
Liabilities:                                
Recurring fair value measurements:                                
Contingent consideration   $ 15,766     $     $     $ 15,766  

    December 31, 2025
    Total   Level 1   Level 2   Level 3
Assets:                
Recurring fair value measurements:                                
Cash equivalents   $ 161,063     $ 161,063     $     $  
Financial instruments owned, at fair value:                                
ETFs     81,737       81,737              
Pass-through GSEs     6,053             6,053        
Other assets—seed capital (WisdomTree Digital Funds):                                
U.S. treasuries     5,402             5,402        
Equities     11,824       11,824              
Fixed income     2,101       1,138       963        
Total   $ 268,180     $ 255,762     $ 12,418     $  
Non-recurring fair value measurements:                                
Fnality International Limited—Series B-1 Preference Shares(1)   $ 8,035     $     $     $ 8,035  
Liabilities:                                
Recurring fair value measurements:                                
Contingent consideration   $ 11,844     $     $     $ 11,844  

(1) Fair value determined on September 10, 2025. Not included in the table above are prospective changes in value due to fluctuations in the British pound to U.S. dollar exchange rate.
Schedule of Instruments

These instruments consist of the following:

    Three Months Ended June 30,   Six Months Ended June 30,
    2026   2025   2026   2025
Other Investments (Note 7)                                
Beginning balance   $     $ 755     $     $ 687  
Net unrealized gains(1)           95             163  
Ending balance   $     $ 850     $     $ 850  
Contingent Consideration:                                
Beginning balance   $ 14,406     $     $ 11,844     $  
Remeasurement(2)     1,360             3,922        
Ending balance   $ 15,766     $     $ 15,766     $  

(1) Recorded in other gains, net in the Consolidated Statements of Operations
(2) Recorded in remeasurement of contingent consideration in the Consolidated Statements of Operations.